Johnson & Johnson replaces signature logo as company shifts focus

Sep 15, 2023

Karah Rucker Anchor/Reporter

By Karah Rucker (Anchor/Reporter), Ian Kennedy (Editor), Brock Koller (Senior Producer)

After more than 130 years, Johnson & Johnson has approved a new logo. The company announced on Thursday, Sept. 14 that it will replace the well-known logo used since 1887.

In a press release, the company said it is updating its logo with a more modern look that better represents the organization’s focus on innovative medicine.

“Our exclusive focus on Innovative Medicine and MedTech solutions enables us to innovate across the full spectrum of healthcare in ways no other company can,” said Joaquin Duato, Chairman of the Board and Chief Executive Officer. “Uniting our diverse businesses under an updated Johnson & Johnson brand reflects our unique ability to reimagine healthcare through transformative innovation, while staying true to Our Credo values and the level of care that patients and doctors expect of us.”

According to a 2017 post on the company website, the original Johnson & Johnson logo has been “one of the longest-used company emblems in the world.” The original logo, based on co-founder James Wood Johnson’s signature, can still be found on certain products for now.

The company has switched its focus to pharmaceuticals and medical devices. Consumer products including Band-Aids, Tylenol, Listerine and baby shampoo now fall under a new company spun off from J&J called Kenvue.

A Kenvue spokesperson said, for now, the original Johnson & Johnson script logo will remain on its products’ packaging but will eventually be phased out, as well.

Despite splitting from its consumer business, Johnson & Johnson expects its full-year 2023 sales to reach as much as $84 billion.

Tags: Health, Johnson and Johnson, prescription drugs

JOHNSON & JOHNSON IS SWITCHING OUT ITS SIGNATURE LOGO AFTER MORE THAN 130 YEARS.

THE FAMOUS SCRIPT LOGO –- BASED ON THE SIGNATURE OF CO-FOUNDER JAMES WOOD JOHNSON — HAS BEEN USED SINCE 1887. IT IS NOW BEING REPLACED BY A MORE MODERN FONT AS THE COMPANY SWITCHES ITS FOCUS TO PHARMACEUTICALS AND MEDICAL DEVICES.

ITS CONSUMER PRODUCTS — INCLUDING BAND-AIDS, TYLENOL, LISTERINE, AND BABY SHAMPOO — NOW FALL UNDER A NEW COMPANY SPUN OFF FROM J AND J – CALLED KENVUE.

A KENVUE SPOKESPERSON SAYS — FOR NOW — THAT ORIGINAL JOHNSON AND JOHNSON SCRIPT LOGO WILL REMAIN ON THEIR PRODUCTS’ PACKAGING BUT WILL EVENTUALLY BE PHASED OUT AS WELL.

DESPITE SPLITTING FROM ITS CONSUMER BUSINESS — JOHNSON AND JOHNSON EXPECTS ITS FULL-YEAR 2023 SALES TO REACH AS MUCH AS EIGHTY-FOUR BILLION DOLLARS ($84 BILLION).